Although clearly detectable, the percentages of CD45+ cells found in the different MIN-O and 4T1 tumor tissue samples are not likely to influence the CXCR4 based discrimination between the MIN-O and the 4T1 tumor lesions. The gene discussed is PTPRC; the disease is neoplasm.